FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W13898768> ?p ?o ?g. }

• W13898768 endingPage "585" @default.
• W13898768 startingPage "576" @default.
• W13898768 abstract "Abstract Anti-B4-blocked Ricin (Anti-B4-bR) is an immunotoxin comprised of the anti-B4 monoclonal antibody (MoAb) and the protein toxin “blocked ricin.” The anti-B4 MoAb is directed against the B-lineage-restricted CD19 antigen expressed on more than 95% of normal and neoplastic B cells. Blocked ricin is an altered ricin derivative that has its nonspecific binding eliminated by chemically blocking the galactose binding domains of the B chain. In vitro cytotoxicity studies demonstrate that the IC37 of Anti-B4-bR is 2 x 10(-11) mol/L compared with 4 x 10(-12) mol/L for native ricin. A phase I dose escalation clinical trial was conducted in 25 patients with refractory B-cell malignancies. Anti-B4-bR was administered by daily 1-hour bolus infusion for 5 consecutive days at doses ranging from 1 microgram/kg/d to 60 micrograms/kg/d. Serum levels above 1 nmol/L were achieved transiently in the majority of patients treated at the maximum tolerated dose of 50 micrograms/kg/d for 5 days for a total dose of 250 micrograms/kg. The dose-limiting toxicity was defined by transient, reversible grade 3 elevations in hepatic transaminases, without impaired hepatic synthetic function. Minor toxicities included transient hypoalbuminemia, thrombocytopenia, and fevers. Human antimouse antibody and human anti-ricin antibody were detected in nine patients. One complete response, two partial responses, and eight mixed or transient responses were observed. These results show the in vitro and in vivo cytotoxicity of Anti-B4-bR and indicate that this immunotoxin can be administered as a daily bolus infusion for 5 days with tolerable, reversible toxicity." @default.
• W13898768 created "2016-06-24" @default.
• W13898768 creator A5005857117 @default.
• W13898768 creator A5008718116 @default.
• W13898768 creator A5023220315 @default.
• W13898768 creator A5038087860 @default.
• W13898768 creator A5046139499 @default.
• W13898768 creator A5055043266 @default.
• W13898768 creator A5062248641 @default.
• W13898768 creator A5064257609 @default.
• W13898768 creator A5075342672 @default.
• W13898768 creator A5086619573 @default.
• W13898768 date "1992-02-01" @default.
• W13898768 modified "2023-10-14" @default.
• W13898768 title "Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion" @default.
• W13898768 cites W137223537 @default.
• W13898768 cites W145681448 @default.
• W13898768 cites W1487790620 @default.
• W13898768 cites W1489775606 @default.
• W13898768 cites W1533725999 @default.
• W13898768 cites W1548735291 @default.
• W13898768 cites W1564925934 @default.
• W13898768 cites W1586747665 @default.
• W13898768 cites W1598727887 @default.
• W13898768 cites W1940241583 @default.
• W13898768 cites W1976719626 @default.
• W13898768 cites W197737620 @default.
• W13898768 cites W1998770834 @default.
• W13898768 cites W2012470334 @default.
• W13898768 cites W2046110140 @default.
• W13898768 cites W2055349933 @default.
• W13898768 cites W206283783 @default.
• W13898768 cites W2094425083 @default.
• W13898768 cites W2104670043 @default.
• W13898768 cites W2142645351 @default.
• W13898768 cites W2151579657 @default.
• W13898768 cites W2152118043 @default.
• W13898768 cites W2153659637 @default.
• W13898768 cites W2167649892 @default.
• W13898768 cites W2243999061 @default.
• W13898768 cites W2269690597 @default.
• W13898768 cites W2302517871 @default.
• W13898768 cites W2409092272 @default.
• W13898768 cites W2409618531 @default.
• W13898768 cites W2413679075 @default.
• W13898768 cites W2473627871 @default.
• W13898768 cites W74992319 @default.
• W13898768 cites W85464595 @default.
• W13898768 doi "https://doi.org/10.1182/blood.v79.3.576.576" @default.
• W13898768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1370636" @default.
• W13898768 hasPublicationYear "1992" @default.
• W13898768 type Work @default.
• W13898768 sameAs 13898768 @default.
• W13898768 citedByCount "166" @default.
• W13898768 countsByYear W138987682012 @default.
• W13898768 countsByYear W138987682013 @default.
• W13898768 countsByYear W138987682014 @default.
• W13898768 countsByYear W138987682015 @default.
• W13898768 countsByYear W138987682016 @default.
• W13898768 countsByYear W138987682017 @default.
• W13898768 crossrefType "journal-article" @default.
• W13898768 hasAuthorship W13898768A5005857117 @default.
• W13898768 hasAuthorship W13898768A5008718116 @default.
• W13898768 hasAuthorship W13898768A5023220315 @default.
• W13898768 hasAuthorship W13898768A5038087860 @default.
• W13898768 hasAuthorship W13898768A5046139499 @default.
• W13898768 hasAuthorship W13898768A5055043266 @default.
• W13898768 hasAuthorship W13898768A5062248641 @default.
• W13898768 hasAuthorship W13898768A5064257609 @default.
• W13898768 hasAuthorship W13898768A5075342672 @default.
• W13898768 hasAuthorship W13898768A5086619573 @default.
• W13898768 hasBestOaLocation W138987681 @default.
• W13898768 hasConcept C115085202 @default.
• W13898768 hasConcept C126322002 @default.
• W13898768 hasConcept C150903083 @default.
• W13898768 hasConcept C159654299 @default.
• W13898768 hasConcept C185592680 @default.
• W13898768 hasConcept C203014093 @default.
• W13898768 hasConcept C207001950 @default.
• W13898768 hasConcept C2777200438 @default.
• W13898768 hasConcept C2777367657 @default.
• W13898768 hasConcept C29730261 @default.
• W13898768 hasConcept C43376680 @default.
• W13898768 hasConcept C542903549 @default.
• W13898768 hasConcept C55493867 @default.
• W13898768 hasConcept C71924100 @default.
• W13898768 hasConcept C86803240 @default.
• W13898768 hasConcept C98274493 @default.
• W13898768 hasConceptScore W13898768C115085202 @default.
• W13898768 hasConceptScore W13898768C126322002 @default.
• W13898768 hasConceptScore W13898768C150903083 @default.
• W13898768 hasConceptScore W13898768C159654299 @default.
• W13898768 hasConceptScore W13898768C185592680 @default.
• W13898768 hasConceptScore W13898768C203014093 @default.
• W13898768 hasConceptScore W13898768C207001950 @default.
• W13898768 hasConceptScore W13898768C2777200438 @default.
• W13898768 hasConceptScore W13898768C2777367657 @default.
• W13898768 hasConceptScore W13898768C29730261 @default.

• next